To this end, cancer cells rely on increasing the expression and/or activity of the main endogenous antioxidants, glutathione (GSH), and the thioredoxin (Trx) systems, as key adaptive ROS-scavenging mechanisms via a mechanism called redox resetting [18,19]. This evidence concerns the gene TXN and cancer.